Abstract
Although elevated resting heart rate (RHR) has been shown to be associated with mortality in the general population and patients with certain diseases, no study has examined this association in patients with breast cancer. A total of 4786 patients with stage I–III breast cancer were retrospectively selected from the Severance hospital breast cancer registry in Seoul, Korea. RHR was measured at baseline and the mean follow-up time for all patients was 5.0 ± 2.5 years. Hazard ratios (HRs) with 95 % confidence intervals (CIs) were calculated using Cox regression models. After adjustment for prognostic factors, patients in the highest quintile of RHR (≥85 beat per minute (bpm)) had a significantly higher risk of all-cause mortality (HR: 1.57; 95 %CI 1.05–2.35), breast cancer-specific mortality (HR: 1.69; 95 %CI 1.07–2.68), and cancer recurrence (HR: 1.49; 95 %CI 0.99–2.25), compared to those in the lowest quintile (≤67 bpm). Moreover, every 10 bpm increase in RHR was associated with 15, 22, and 6 % increased risk of all-cause mortality, breast cancer-specific mortality, and cancer recurrence, respectively. However, the association between RHR and cancer recurrence was not statistically significant (p = 0.26). Elevated RHR was associated with an increased risk of mortality in patients with breast cancer. The findings from this study suggest that RHR may be used as a prognostic factor for patients with breast cancer in clinical settings.
Similar content being viewed by others
References
Anselmino M, Öhrvik J, Rydén L (2010) Resting heart rate in patients with stable coronary artery disease and diabetes: a report from the euro heart survey on diabetes and the heart. Eur Heart J: ehq368
Bemelmans RH, van der Graaf Y, Nathoe HM, Wassink AM, Vernooij JW, Spiering W, Visseren FL, Group SS (2013) The risk of resting heart rate on vascular events and mortality in vascular patients. Int J Cardiol 168:1410–1415
Benetos A, Rudnichi A, Thomas F, Safar M, Guize L (1999) Influence of heart rate on mortality in a French population role of age, gender, and blood pressure. Hypertension 33:44–52
Böhm M, Cotton D, Foster L, Custodis F, Laufs U, Sacco R, Bath PM, Yusuf S, Diener H-C (2012) Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J 33:2804–2812
Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators S (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376:886–894
Diaz A, Bourassa MG, Guertin MC, Tardif JC (2005) Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26:967–974. doi:10.1093/eurheartj/ehi190
Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, BERKSON DM, LEPPER M, SCHOENBERGER JA, LINDBERG HA (1980) Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 112:736–749
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386
Fox K, Bousser M-G, Amarenco P, Chamorro A, Fisher M, Ford I, Hennerici MG, Mattle HP, Rothwell PM, Investigators PS (2013) Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population. Int J Cardiol 168:3500–3505
Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372:817–821
Fujiura Y, Adachi H, Tsuruta M, Jacobs DR, Hirai Y, Imaizumi T (2001) Heart rate and mortality in a Japanese general population: an 18-year follow-up study. J Clin Epidemiol 54:495–500
Gillman MW, Kannel WB, Belanger A, D’Agostino RB (1993) Influence of heart rate on mortality among persons with hypertension: the framingham study. Am Heart J 125:1148–1154
Greenland P, Daviglus ML, Dyer AR, Liu K, Huang CF, Goldberger JJ, Stamler J (1999) Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the chicago heart association detection project in industry. Am J Epidemiol 149:853–862
Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J clin oncol 28:2784–2795. doi:10.1200/jco.2009.25.6529
Hillis G, Woodward M, Rodgers A, Chow C, Li Q, Zoungas S, Patel A, Webster R, Batty G, Ninomiya T (2012) Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia 55:1283–1290
Jensen MT, Marott JL, Allin KH, Nordestgaard BG, Jensen GB (2012) Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the copenhagen city heart study. Eur J of preventive cardiol 19:102–108
Jensen MT, Suadicani P, Hein HO, Gyntelberg F (2013) Elevated resting heart rate, physical fitness and all-cause mortality: a 16-year follow-up in the copenhagen male study. Heart 99:882–887
Jouven X, Escolano S, Celermajer D, Empana JP, Bingham A, Hermine O, Desnos M, Perier MC, Marijon E, Ducimetiere P (2011) Heart rate and risk of cancer death in healthy men. PLoS ONE 6:e21310. doi:10.1371/journal.pone.0021310
Jouven X, Zureik M, Desnos M, Guérot C, Ducimetière P (2001) Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res 50:373–378
Kannel WB, Kannel C, Paffenbarger RS, Cupples LA (1987) Heart rate and cardiovascular mortality: the framingham study. Am Heart J 113:1489–1494
Kolloch R, Legler UF, Champion A, Cooper-DeHoff RM, Handberg E, Zhou Q, Pepine CJ (2008) Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J
Kristal-Boneh E, Silber H, Harari G, Froom P (2000) The association of resting heart rate with cardiovascular, cancer and all-cause mortality. eight year follow-up of 3527 male israeli employees (the CORDIS Study). Eur Heart J 21:116–124. doi:10.1053/euhj.1999.1741
Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, Yusuf S, Böhm M (2014) Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol 103:149–159
Mensink G, Hoffmeister H (1997) The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J 18:1404–1410
Perskly V, Dyer AR, Leonas J, Stamler J, Berkson DM, Lindberg HA, Paul O, Shekelle RB, Lepper MH, Schoenberger JA (1981) Heart rate: a risk factor for cancer? Am J Epidemiol 114:477–487
Reunanen A, Karjalainen J, Ristola P, Heliövaara M, Knekt P, Aromaa A (2000) Heart rate and mortality. J Intern Med 247:231–239
Saxena A, Minton D, Lee D-c, Sui X, Fayad R, Lavie CJ, Blair SN (2013) Protective role of resting heart rate on all-cause and cardiovascular disease mortality. In: Mayo Clinic Proceedings. Elsevier, p 1420–1426
Stettler C, Bearth A, Allemann S, Zwahlen M, Zanchin L, Deplazes M, Christ E, Teuscher A, Diem P (2007) QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia 50:186–194
Thomas F, Guize L, Bean K, Benetos A (2001) Pulse pressure and heart rate: independent risk factors for cancer? J Clin Epidemiol 54:735–740
Thomas F, Rudnichi A, Bacri A-M, Bean K, Guize L, Benetos A (2001) Cardiovascular mortality in hypertensive men according to presence of associated risk factors. Hypertension 37:1256–1261
Wang A, Chen S, Wang C, Zhou Y, Wu Y, Xing A, Luo Y, Huang Z, Liu X, Guo X (2014) Resting heart rate and risk of cardiovascular diseases and all-cause death: the Kailuan study
Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: american society of clinical oncology/college of american pathologists clinical practice guideline update. J clin oncol 31:3997–4013. doi:10.1200/jco.2013.50.9984
Funding
This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2015S1A5B8036349).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of interest
None declared.
Additional information
Dong Hoon Lee and Seho Park have equally contributed to this study.
Rights and permissions
About this article
Cite this article
Lee, D.H., Park, S., Lim, S.M. et al. Resting heart rate as a prognostic factor for mortality in patients with breast cancer. Breast Cancer Res Treat 159, 375–384 (2016). https://doi.org/10.1007/s10549-016-3938-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-016-3938-1